CARVIFINE 6.25 TAB

Uses of CARVIFINE 6.25 TAB

CARVIFINE 6.25 TAB is prescribed for the management of several critical cardiovascular conditions to improve patient outcomes and quality of life.

• Hypertension (High Blood Pressure)

  CARVIFINE 6.25 TAB is effective in lowering elevated blood pressure, reducing the risk of associated complications like stroke, heart attack, and kidney problems. It works by relaxing blood vessels and slowing the heart rate, making it easier for the heart to pump blood throughout the body. Regular use, as prescribed, helps maintain blood pressure within a healthy range.

• Chronic Heart Failure

  This medication is crucial in the long-term management of stable symptomatic chronic heart failure. It helps to improve the heart's pumping efficiency, reduce symptoms such as shortness of breath and fatigue, and decrease hospitalizations. Carvedilol is known to improve survival rates and overall quality of life for patients suffering from this condition.

• Post-Myocardial Infarction (Heart Attack)

  CARVIFINE 6.25 TAB may be prescribed after a heart attack to improve cardiac function and reduce the risk of subsequent cardiovascular events. It helps protect the heart from further damage by reducing its workload and improving blood flow, especially in patients with left ventricular dysfunction.

Side Effects of CARVIFINE 6.25 TAB

Like all medications, CARVIFINE 6.25 TAB can cause side effects, although not everybody gets them. Most side effects are mild to moderate and temporary. If any of these effects bother you or persist, consult your doctor.

While less common, some serious side effects can occur. Seek immediate medical attention if you experience any of these rare but severe symptoms.

It is important to report any unusual or severe symptoms to your doctor promptly. Do not stop taking the medication without consulting your healthcare provider, as abrupt withdrawal can worsen your condition.

How to use CARVIFINE 6.25 TAB

• Adults:

  The typical starting dose for hypertension is 6.25 mg twice daily, which may be gradually increased by your doctor based on response. For heart failure, the starting dose is usually lower, often 3.125 mg twice daily, and titrated upwards over several weeks under strict medical supervision. Always take with food to slow absorption and reduce the risk of orthostatic hypotension.

• Children:

  The safety and efficacy of CARVIFINE 6.25 TAB in children and adolescents under 18 years of age have not been established. Therefore, its use is generally not recommended in this age group unless specifically advised by a pediatric cardiologist in rare cases.

• Elderly:

  Elderly patients may be more sensitive to the effects of Carvedilol. A lower starting dose and careful titration are often recommended. Close monitoring for blood pressure, heart rate, and potential side effects is essential to ensure safe and effective treatment.

• Missed Dose:

  If you miss a dose of CARVIFINE 6.25 TAB, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for a missed one, as this can increase the risk of side effects.

How CARVIFINE 6.25 TAB works

Carvedilol, the active ingredient in CARVIFINE 6.25 TAB, exerts its therapeutic effects through a unique dual mechanism of action. It acts as a non-selective beta-adrenergic receptor blocker, meaning it blocks both beta-1 receptors in the heart and beta-2 receptors in the lungs and blood vessels. This beta-blocking action reduces heart rate, myocardial contractility, and cardiac output, thereby lowering blood pressure and reducing the heart's oxygen demand. Additionally, Carvedilol is a selective alpha-1 adrenergic receptor blocker. By blocking alpha-1 receptors, particularly in the peripheral vasculature, it causes vasodilation (widening of blood vessels). This alpha-blocking effect contributes to its antihypertensive action by reducing peripheral vascular resistance. The combination of beta-blockade and alpha-1 blockade provides a comprehensive approach to managing hypertension and heart failure, improving hemodynamic parameters and overall cardiovascular function.

Precautions

• Inform your doctor if you have asthma, chronic obstructive pulmonary disease (COPD), or any other respiratory conditions.
• Use with caution in patients with diabetes, as Carvedilol can mask symptoms of low blood sugar.
• Patients with severe liver impairment should not use this medication.
• Avoid abrupt discontinuation of CARVIFINE 6.25 TAB, as it can worsen angina or precipitate a heart attack.
• Inform your doctor about all other medications, including over-the-counter drugs and herbal supplements, to avoid potential drug interactions.
• Use with caution in patients with peripheral vascular disease or Raynaud's phenomenon.

Safety Advice

Alcohol

CAUTION

Consuming alcohol while taking CARVIFINE 6.25 TAB can significantly lower your blood pressure and increase the risk of dizziness, lightheadedness, or fainting. It is advisable to limit or avoid alcohol intake during treatment.

Pregnancy

CONSULT YOUR DOCTOR

CARVIFINE 6.25 TAB is generally not recommended during pregnancy unless clearly necessary, as it may affect the fetus. Always discuss the potential risks and benefits with your doctor before use if you are pregnant or planning a pregnancy.

Breastfeeding

CONSULT YOUR DOCTOR

Carvedilol is known to pass into breast milk and may affect the nursing infant. It is crucial to consult your doctor to weigh the benefits of breastfeeding against the potential risks to the baby before taking this medication.

Driving

UNSAFE

CARVIFINE 6.25 TAB can cause dizziness, fatigue, or lightheadedness, especially when you first start taking it or when the dose is increased. Avoid driving or operating heavy machinery until you know how the medication affects you.

Kidney

CAUTION

Patients with kidney disease should use CARVIFINE 6.25 TAB with caution. Dose adjustments may be necessary, and regular monitoring of kidney function is recommended. Always consult your doctor for personalized advice.

Liver

UNSAFE

CARVIFINE 6.25 TAB is extensively metabolized in the liver, and its use is contraindicated in patients with severe liver impairment. For mild to moderate liver issues, dose adjustments and close monitoring are required. Consult your doctor immediately if you notice symptoms of liver problems.

Fact Box

Frequently asked questions by patients

Frequently Asked Questions

Additional Information